ENVALITH
株式会社FIXER logo

FIXER Inc.

5129Growth MarketInformation & Communication

株式会社FIXER logo
FIXER Inc.5129

Cloud Services Business (FIXER Inc. single segment)

A cloud integrator driving business transformation centered on its generative AI platform "GaiXer"

PeriodCurrentPreviousChange
Revenue (cumulative nine months of FY2026, ending August 2026)¥2,356 million¥1,563 million (cumulative six months of FY2026, ending August 2026)
Operating loss (cumulative nine months of FY2026, ending August 2026)△¥1,878 million△¥1,729 million (full year FY2025, ended August 2025)
Ordinary loss (cumulative nine months of FY2026, ending August 2026)△¥1,873 million
Quarterly net loss attributable to owners of parent (cumulative nine months of FY2026, ending August 2026)△¥1,842 million
Gross loss (cumulative nine months of FY2026, ending August 2026)△¥11 million
Total assets (as of May 31, 2026)¥2,942 million¥4,493 million (as of August 31, 2025)
Net assets (as of May 31, 2026)¥2,331 million¥3,807 million (as of August 31, 2025)
Equity ratio (as of May 31, 2026)78.8%83.7% (as of August 31, 2025)
Quarterly net loss per share (cumulative nine months of FY2026, ending August 2026)△¥122.86
Revenue (full-year forecast, FY2026 ending August 2026)¥4,348 million (+9.2% YoY)¥3,980 million (full year FY2025, ended August 2025)
Operating loss (full-year forecast, FY2026 ending August 2026)△¥1,546 million△¥1,729 million (full year FY2025, ended August 2025)
Revenue by service - Resale (cumulative nine months)¥1,167 million
Revenue by service - Managed Service (cumulative nine months)¥478 million
Revenue by service - Project-based Services (cumulative nine months)¥504 million
Revenue by service - SaaS (cumulative nine months)¥195 million
Revenue by service - Sovereign AI (cumulative nine months)¥5 million
Cash and deposits (as of May 31, 2026)¥1,718 million¥3,088 million (as of August 31, 2025)

Business Details

FIXER is a cloud integrator with strength in building cloud-native enterprise systems centered on Microsoft Azure. The company operates five services—Project-based Services, Resale, Managed Service, SaaS, and Sovereign AI—with government agencies, financial institutions, and medical institutions as its main customers. It is promoting a shift from its traditional Project-based Services-centered model toward a recurring-revenue business model centered on the on-premises AI platform "Sovereign GaiXer."

Recent Overview

Formal order-taking for Sovereign GaiXer began and medical AI expansion accelerated, but large losses continued due to the end of large-scale projects and upfront investment

Revenue for the cumulative nine months of FY2026 (ending August 2026, September 2025 through May 2026) was ¥2,356 million, with an operating loss of ¥1,878 million. In addition to the decline in revenue and profit due to the completion of large-scale projects (related to the Expo, etc.), upfront investment related to Sovereign GaiXer product development, restructuring of the sales organization, and development of sales channels expanded the loss. Sovereign GaiXer began formal order-taking from April 2026, with multi-unit connectivity functionality implemented and internal use commenced. The sales structure was transitioned to an integrated proposal system combining the cloud version and Sovereign GaiXer. In the medical field, GaiXer Medical Agent was deployed at Fujita Health University Okazaki Medical Center and Saiseikai Mukojima Hospital, and sales activities for AI Ijikacho commenced. As part of a review of cost classification, a portion of cloud usage fees and outsourcing expenses previously recorded as selling, general and administrative expenses was reclassified to cost of sales, resulting in a gross loss of ¥11 million. Cash and deposits decreased by ¥1,370 million from the end of the previous fiscal year to ¥1,718 million. There has been no change to the full-year earnings forecast (revenue of ¥4,348 million, operating loss of △¥1,546 million), which is premised on a recovery in profitability in the fourth quarter.

Key Products

platform
GaiXer

A cloud-native platform providing enterprise generative AI services on the Microsoft Azure infrastructure. It has a cumulative adoption track record of over 205 companies and serves as the core of SaaS revenue.

platform
Sovereign GaiXer

An on-premises AI platform addressing the data sovereignty needs of government agencies, financial institutions, and other organizations. Formal order-taking began in April 2026. The company has implemented multi-unit connectivity functionality, begun internal use, and is developing its sales agent network. It has transitioned to an integrated sales structure providing the cloud version of GaiXer on Sovereign GaiXer.

product
GaiXer Medical Agent

A medical-specialized AI agent being deployed at Fujita Health University Okazaki Medical Center and Saiseikai Mukojima Hospital. The company is promoting its social implementation in the medical DX market.

product
AI Ijikacho

An AI product for medical office administration, with sales activities commencing from the third quarter of FY2026 (ending August 2026). It is positioned as a new revenue source in the medical field.

service
cloud.config (Managed Service)

A managed service that constitutes one pillar of recurring revenue. Revenue for the cumulative nine months of FY2026 (ending August 2026) was ¥478 million.

service
Project-based Services

The company's traditional core business. Revenue has been on a declining trend due to the completion of large-scale projects (related to the Expo, etc.), and a shift toward recurring revenue is underway. Revenue for the cumulative nine months of FY2026 (ending August 2026) was ¥504 million.

service
Resale

The largest revenue-contributing segment for the cumulative nine months of FY2026 (ending August 2026), with revenue of ¥1,167 million. The company leverages its position as Japan's first Microsoft CSP partner.

Growth Drivers

  • Development of the on-premises AI market for government agencies and financial institutions, centered on Sovereign GaiXer (formal order-taking began April 2026)
  • Expansion of GaiXer adoption (surpassing 205 companies cumulatively) as the generative AI market transitions from the PoC stage to full-scale implementation
  • Deployment of new services "GaiXer Medical Agent" and "AI Ijikacho" targeting the medical DX market
  • Strengthened proposal capabilities through transition to an integrated sales structure combining the cloud version of GaiXer and Sovereign GaiXer
  • Expansion of sales channels and indirect sales revenue through development of the sales agent network
  • Shift from Project-based Services toward a recurring revenue structure through Resale, Managed Service, SaaS, and Sovereign AI
  • High brand recognition as a Microsoft Azure partner (Japan's first CSP partner, Microsoft Partner of the Year award history)
  • Optimization of fixed costs and improvement of personnel expenses through restraint on new graduate and mid-career hiring and organizational restructuring

Risks

  • Risk of a sharp decline in revenue and profit due to the completion of large-scale projects (related to the Expo, etc.), which has already materialized in the cumulative nine months (gross loss of △¥11 million)
  • Risk of expanding losses due to continued upfront investment in next-generation AI platforms such as Sovereign GaiXer (cumulative nine-month operating loss of △¥1,878 million, full-year forecast of △¥1,546 million)
  • Cash flow risk due to a sharp decrease in cash and deposits (down ¥1,370 million from the end of the previous fiscal year, to a balance of ¥1,718 million)
  • With Sovereign GaiXer's formal order-taking having only recently begun (April 2026), revenue contribution in the fourth quarter is a precondition for achieving the full-year forecast, but results are not yet confirmed
  • Financial constraints due to the complete non-recognition of deferred tax assets (no recoverability of future taxable income)
  • Deterioration of the competitive environment due to intensifying entry by major system integrators and cloud vendors into the generative AI market
  • Risk of revenue concentration among specific customers (Digital Agency 16.5%, Expo Association 16.0%, Yamato System Development 11.2%, Daiwa Asset 11.0%)
  • Dilution risk from the exercise of stock acquisition rights issued to EVO FUND (number of shares outstanding increased from 14,798,100 shares at the end of the previous fiscal year to 15,657,400 shares)
  • Structural deterioration of gross margin due to the reclassification of cost items (partial transfer of cloud usage fees and outsourcing expenses to cost of sales)
  • Difficulty in securing and developing talented engineering personnel (a young organization with an average age of 28.3 years)

Last updated: November 27, 2025